Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Global gene expression profiling of FOP- or resFOP-iMSCs treated by several ligands


ABSTRACT: Analyzed differentially expressed genes among FOP- or resFOP-iMSCs treated by several ligands: Activin-A, 100 ng/mL; BMP-7, 100 ng/mL; TGF-B3, 10 ng/mL Comparison of gene expressions among FOP- or resFOP-iMSCs treated 16h by several ligands

ORGANISM(S): Homo sapiens

SUBMITTER: Makoto Ikeya 

PROVIDER: E-GEOD-62783 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Neofunction of ACVR1 in fibrodysplasia ossificans progressiva.

Hino Kyosuke K   Ikeya Makoto M   Horigome Kazuhiko K   Matsumoto Yoshihisa Y   Ebise Hayao H   Nishio Megumi M   Sekiguchi Kazuya K   Shibata Mitsuaki M   Nagata Sanae S   Matsuda Shuichi S   Toguchida Junya J  

Proceedings of the National Academy of Sciences of the United States of America 20151130 50


Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disease characterized by extraskeletal bone formation through endochondral ossification. FOP patients harbor point mutations in ACVR1 (also known as ALK2), a type I receptor for bone morphogenetic protein (BMP). Two mechanisms of mutated ACVR1 (FOP-ACVR1) have been proposed: ligand-independent constitutive activity and ligand-dependent hyperactivity in BMP signaling. Here, by using FOP patient-derived induced pluripotent stem cells (F  ...[more]

Similar Datasets

2015-12-09 | E-GEOD-69459 | biostudies-arrayexpress
2015-12-09 | GSE62783 | GEO
2022-05-12 | GSE183525 | GEO
| PRJNA756286 | ENA
2006-12-31 | E-MEXP-566 | biostudies-arrayexpress
2011-01-13 | E-GEOD-26594 | biostudies-arrayexpress
2014-02-18 | E-GEOD-44849 | biostudies-arrayexpress
2010-07-30 | E-GEOD-22637 | biostudies-arrayexpress
2014-09-30 | E-MTAB-2704 | biostudies-arrayexpress
2009-12-31 | E-MEXP-1997 | biostudies-arrayexpress